CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Global Wholehealth Partners Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Global Wholehealth Partners Corp
1130 Calle Cordillera
Phone: (714) 392-4112p:714 392-4112 SAN CLEMENTE, CA  92673  United States Ticker: GWHPGWHP
On 5/3/2024, the Securities and Exchange Commission (SEC) charged BF Borgers CPA PC and its owner, Benjamin F. Borgers, with significant violations of Public Company Accounting Oversight Board (PCAOB) standards across more than 1,500 SEC filings from January 2021 to June 2023. The charges included falsely representing compliance with PCAOB standards to clients, fabricating audit documentation, and inaccurately stating compliance in audit reports. According to the SEC's order, of 369 BF Borgers' clients whose public filings from January 2021 through June 2023 incorporated the firm's audits and reviews, at least 75 percent of the filings incorporated audits and reviews that did not comply with PCAOB standards. The financials in this report may include past audits and reviews conducted by BF Borgers CPA PC that are deemed not compliant with PCAOB standards.
Business Summary
Global WholeHealth Partners Corporation develops and markets in-vitro diagnostic tests for over the counter (OTC), or consumer-use and point-of-care (POC), which includes hospitals, physicians’ offices and medical clinics, including those within penal systems throughout the United States and abroad. The Company markets a range of diagnostic test kits for consumer use through OTC sales, and for use by health care professionals, generally located at medical clinics, physician offices and hospitals known as POC, in the United States. These test kits are known as in-vitro diagnostic test kits or IVD products. The Company has its manufacturing, warehousing and laboratories in San Diego and Escondido, California.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20226/30/2022YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Treasurer, Comp F. ReneAlvarez 84 7/27/2022 7/12/2022
Executive Vice President, Director Edgar B.Gonzalez 58 7/27/2022 7/27/2022

Business Names
Business Name
GWHP
TXJK
TXJKD

General Information
Outstanding Shares: 131,287,079 (As of 10/13/2022)
Shareholders: 384
Stock Exchange: OTC
Federal Tax Id: 462316220


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, May 10, 2024